The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should see earnings gains through the end of the decade.

"We are very confident with both the auto-injectors and the vials that we will be able to supply the needs in the U.S. marketplace," he said, adding that a big chunk of patients do not progress to ...

By Maggie Fick and Louise Rasmussen Sept 20 (Reuters) - Swiss medical technology company Ypsomed YPSN.S announced on Wednesday a long-term supply deal with Novo Nordisk NOVOb.CO for autoinjectors ...

Meanwhile, the company signed on to a long-term manufacturing deal with Novo Nordisk to provide autoinjectors for the drugmaker’s blockbuster GLP-1 drugs Wegovy and Ozempic.

Lilly launches lower-price weight loss drug without injector pen By Deidre McPhillips, CNN | Posted - Aug. 27, 2024 at 2:36 p.m.

It targets two hormone receptors, GIP and GLP-1. Semgalutide, known as Ozempic for diabetes and Wegovy for weight loss, is also part of this broad class of drugs.

It targets two hormone receptors, GIP and GLP-1. Semgalutide, known as Ozempic for diabetes and Wegovy for weight loss, is also part of this broad class of drugs.